Authors: Anscher, MS Marks, LB Shafman, TD Clough, R Huang, H Tisch, A Munley, M Herndon, JE Garst, J Crawford, J Jirtle, RL

Citation: Ms. Anscher et al., Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation, J CL ONCOL, 19(17), 2001, pp. 3758-3765

Authors: Hernando, ML Marks, LB Bentel, GC Zhou, SM Hollis, D Das, SK Fan, M Munley, MT Shafman, TD Anscher, MS Lind, PA

Citation: Ml. Hernando et al., Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer, INT J RAD O, 51(3), 2001, pp. 650-659

Authors: Fan, M Marks, LB Lind, P Hollis, D Woel, RT Bentel, GG Anscher, MS Shafman, TD Coleman, RE Jaszczak, RJ Munley, MT

Citation: M. Fan et al., Relating radiation-induced regional lung injury to changes in pulmonary function tests, INT J RAD O, 51(2), 2001, pp. 311-317

Authors: Shafman, TD Levitz, S Nixon, AJ Gibans, LA Nichols, KE Bell, DW Ishioka, C Isselbacher, KJ Gelman, R Garber, J Harris, JR Haber, DA

Citation: Td. Shafman et al., Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor, GENE CHROM, 27(2), 2000, pp. 124-129

Authors: Cokgor, I Akabani, G Kuan, CT Friedman, HS Friedman, AH Coleman, RE McLendon, RE Bigner, SH Zhao, XG Garcia-Turner, AM Pegram, CN Wikstrand, CJ Shafman, TD Herndon, JE Provenzale, JM Zalutsky, MR Bigner, DD

Citation: I. Cokgor et al., Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas, J CL ONCOL, 18(22), 2000, pp. 3862-3872